Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer

The 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, also known as statins, are administered as first-line therapy for hypercholesterolemia, both as primary and secondary prevention. Besides the lipid-lowering effect, statins have been suggested to inhibit the development of car...

Descripción completa

Detalles Bibliográficos
Autores principales: Morofuji, Yoichi, Nakagawa, Shinsuke, Ujifuku, Kenta, Fujimoto, Takashi, Otsuka, Kaishi, Niwa, Masami, Tsutsumi, Keisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877351/
https://www.ncbi.nlm.nih.gov/pubmed/35215263
http://dx.doi.org/10.3390/ph15020151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877351/
https://www.ncbi.nlm.nih.gov/pubmed/35215263
http://dx.doi.org/10.3390/ph15020151

Ejemplares similares